Apic Bio's Seed Round

Apic Bio raised a round of funding on August 23, 2017.

Apic Bio is a pre-clinical stage gene therapy company leveraging its proprietary platform to advance therapies to treat rare diseases with complex mechanisms, in particular Alpha-1 Antitrypsin Deficie…

Articles about Apic Bio's Seed Round: